Pioglitazone Hydrochloride and Metformin Hydrochloride

AvKARE🇺🇸 United States

FDA Page

Effective Date: Mar 13, 2023
Approval ID: f6cd8da3-92cb-8800-e053-6394a90a3713
Products: 2 registered
Version: 1

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets, USP Rx Only These highlights do not include all the information needed to use PIOGLITAZONE AND METFORMIN HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for PIOGLITAZONE AND METFORMIN HYDROCHLORIDE TABLETS. Initial U.S. Approval: 2005

Quick Stats

Total Products2

Labelers2

Label Sections24

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.